Clinical Trials Browser

Interventional × Polycythemia × 1 year × Clear all

NCT07527221 2026-06-01

Safety and Tolerability of ZE74-0282 in Healthy Volunteers

Phase 1 Recruiting

MyeloidOther hematologic neoplasm

Polycythemia, Thrombocythemia, Essential, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT07341048 2026-01-15

ACTIVAQ

Phase NA Not yet recruiting

Polycythemia, Polycythemia Vera

NCT04576156 2025-12-04

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

Phase 3 Active not recruiting

Myeloproliferative Disorders, Polycythemia, Thrombocytosis, Primary Myelofibrosis

NCT03008642 2025-09-19

Poly-CO

Phase NA Completed

Myeloproliferative Disorders, Polycythemia

NCT05481151 2025-08-13

A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV

Phase 3 Active not recruiting

Polycythemia, Polycythemia Vera, Thrombocythemia, Essential